Back to search
IgE-Mediated Hypersensitivity
Clinical trial pipeline · Data from ClinicalTrials.gov
See which IgE-Mediated Hypersensitivity trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which IgE-Mediated Hypersensitivity trials you may qualify forThis study is researching an experimental drug called linvoseltamab combined with another drug called dupilumab. The study is looking at patients who have sever…
Phase 2b Study of RPT904 as Monotherapy in Participants With IgE-Mediated Food Allergy: This is a Phase 2b randomized, double-blind, placebo-controlled clinical…
The goal of this clinical trial is to see if a new formula based on hydrolysed rice proteins (Rice formula) is well tolerated by infants and young children with…
In this study, the investigators want to find out whether a specific medication commonly used for severe allergic reactions is really necessary. When children h…
Previous research has shown that some patients with atopic eczema have specific self-reactive antibodies, known as IgE autoantibodies, that react to their own s…
Food allergy affects 1 in 30 children, and is the commonest trigger for life-threatening reactions (anaphylaxis) in this age group. It is a major public health…
The goal of this study is to test the safety and feasibility of a change in management approach for infants with newly diagnosed egg allergy. Infants with newly…
The purpose of this study is to evaluate the pharmacodynamics, safety, tolerability, pharmacokinetics, and immunogenicity of cizutamig in IgE Mediated Diseases.
The purpose of the study is to determine whether therapeutic education can improve the quality of life of the child from 8 to 12 years old suffering of food all…